Diaceutics PLC (LSE: DXRX) is a data analytics and diagnostics commercialisation company serving the precision medicine sector. It provides pharma companies with insights and infrastructure to optimise test adoption and patient identification in global drug launches. The company’s DXRX platform integrates real-world data and lab networks to streamline diagnostic pathways, supporting faster, more effective personalised therapies. With a focus on improving patient outcomes, Diaceutics operates at the forefront of precision healthcare.
Latest shares articles
Capital.com enhances EU client protection with $1 million insurance cover
Capital.com announced the launch of a new enhanced insurance scheme specifically for clients across the European Union (EU).
14 hours ago
Buffett’s cash pile just got even larger
Warren Buffett just announced he's stepping down as CEO of Berkshire Hathaway – and he's leaving his successor a massive pile of cash. Since 2024, Buffett has sold off a massive amount of stock, more than doubling Berkshire's cash position from $167bn to $348bn.
18:05, 25 June 2025
Why the Federal Reserve is ignoring a major economic warning
Economic uncertainty is at an all-time high. It’s higher today than during the pandemic in 2020—and several times higher than during the Great Recession in 2008.
17:01, 25 June 2025
Oil price forecast 2025-2030: Third-party price target
Discover third-party oil price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
16:03, 25 June 2025
Ratings and Reviews
Ratings and Reviews
